?:authorAffiliation
|
-
[\'Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.\', \'School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.\', \'Pediatric Intensive Care Department, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain.\', \'Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.\', \'Internal Medicine Department, Infectious Diseases Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.\', \'School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. pedro.oliva@salud.madrid.org.\', \'Pediatric Intensive Care Department, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain. pedro.oliva@salud.madrid.org.\', \'Clinical Pharmacology Department, Clinical Trial Unit, La Paz University Hospital - IdiPAZ, Paseo de la Castellana, 261, 28046, Madrid, Spain. alberto.borobia@salud.madrid.org.\', \'School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. alberto.borobia@salud.madrid.org.\']
|